Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Montano

Showing results (161-170 of 190) with videos related to

Pageof 19
Sort By:
Journal of Pediatric Gastroenterology and Nutrition|August 3, 2020
Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis ConsortiumTrevor J Laborda, Amanda Ricciuto, Madeleine Aumar, et al.
The American Journal of Gastroenterology|July 25, 2024
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
The American Journal of Gastroenterology|January 31, 2025
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune HepatitisCumali Efe, Hannes Hagström, Henriette Ytting, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialMichael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Journal of Gastroenterology and Hepatology|August 14, 2020
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcomeCumali Efe, Murat Torgutalp, Ida Henriksson, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 9, 2023
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteriaBerend R Beumer, Jeroen L A van Vugt, Gonzalo Sapisochin, et al.
Hepatology (Baltimore, Md.)|September 9, 2024
Efficacy and safety of infliximab in patients with autoimmune hepatitisCumali Efe, Ellina Lytvyak, Tuğçe Eşkazan, et al.
Pageof 19

Showing results (161-170 of 190) with videos related to

Sort By:
Pageof 19
Journal of Pediatric Gastroenterology and Nutrition|August 3, 2020
Vedolizumab Therapy in Children With Primary Sclerosing Cholangitis: Data From the Pediatric Primary Sclerosing Cholangitis ConsortiumTrevor J Laborda, Amanda Ricciuto, Madeleine Aumar, et al.
The American Journal of Gastroenterology|July 25, 2024
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
The American Journal of Gastroenterology|January 31, 2025
Severe Cholestasis Predicts Recurrent Primary Sclerosing Cholangitis Following Liver TransplantationBishoi Aziz, Beverley Kok, Matthew Cheah, et al.
Gastroenterology|October 9, 2018
Factors Associated With Recurrence of Primary Biliary Cholangitis After Liver Transplantation and Effects on Graft and Patient SurvivalAldo J Montano-Loza, Bettina E Hansen, Christophe Corpechot, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 13, 2017
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune HepatitisCumali Efe, Hannes Hagström, Henriette Ytting, et al.
The Lancet. Gastroenterology & Hepatology|October 31, 2025
Cilofexor in non-cirrhotic primary sclerosing cholangitis (PRIMIS): a randomised, double-blind, multicentre, placebo-controlled, phase 3 trialMichael Trauner, Cynthia Levy, Atsushi Tanaka, et al.
Journal of Gastroenterology and Hepatology|August 14, 2020
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcomeCumali Efe, Murat Torgutalp, Ida Henriksson, et al.
Journal of Hepatology|October 6, 2023
Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitisFrancesca Colapietro, Patrick Maisonneuve, Ellina Lytvyak, et al.
Journal of Cachexia, Sarcopenia and Muscle|January 9, 2023
Impact of muscle mass on survival of patients with hepatocellular carcinoma after liver transplantation beyond the Milan criteriaBerend R Beumer, Jeroen L A van Vugt, Gonzalo Sapisochin, et al.
Hepatology (Baltimore, Md.)|September 9, 2024
Efficacy and safety of infliximab in patients with autoimmune hepatitisCumali Efe, Ellina Lytvyak, Tuğçe Eşkazan, et al.
Pageof 19